<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03987529</url>
  </required_header>
  <id_info>
    <org_study_id>H1906-096-1040</org_study_id>
    <nct_id>NCT03987529</nct_id>
  </id_info>
  <brief_title>Effects of Volatile and Intravenous Anesthetics on Pupillary Function</brief_title>
  <official_title>Comparison of Effects of Volatile and Intravenous Anesthetics on Pupillary Function During General Anesthesia in Children; a Prospective Observational Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare of effects of volatile and intravenous anesthetics on pupillary function during&#xD;
      general anesthesia in children&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigator will measure the pupillary function with pupillometry during general&#xD;
      anesthesia with volatile or intravenous anesthetics in children.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 12, 2020</start_date>
  <completion_date type="Anticipated">February 28, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>NPi</measure>
    <time_frame>1hour afer skin incision</time_frame>
    <description>Neurological Pupil index</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>%CH</measure>
    <time_frame>1. Stage of loss of consciousness after induction with bolus propofol 2. Before and after tracheal intubation 3. Skin incision 4. 1hour afer skin incision 5. Just before extubation</time_frame>
    <description>% change of pupil size</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CV</measure>
    <time_frame>1. Stage of loss of consciousness after induction with bolus propofol 2. Before and after tracheal intubation 3. Skin incision 4. 1hour afer skin incision 5. Just before extubation</time_frame>
    <description>Constriction Velocity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>DV</measure>
    <time_frame>1. Stage of loss of consciousness after induction with bolus propofol 2. Before and after tracheal intubation 3. Skin incision 4. 1hour afer skin incision 5. Just before extubation</time_frame>
    <description>Dilation Velocity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NPi</measure>
    <time_frame>1. Stage of loss of consciousness after induction with bolus propofol 2. Before and after tracheal intubation 3. Skin incision 4. 1hour afer skin incision 5. Just before extubation</time_frame>
    <description>Neurological Pupil index</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">22</enrollment>
  <condition>Pupillary Functions, Abnormal</condition>
  <arm_group>
    <arm_group_label>Sevoflurane+Remifentanil</arm_group_label>
    <description>Using inhalent agent(Sevoflurane), continuous infusion of Remifentanil</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol+Remifentanil</arm_group_label>
    <description>Using continuous infusion of Propofol and Remifentanil</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>sevoflurane</intervention_name>
    <description>volatile anesthetic</description>
    <arm_group_label>Sevoflurane+Remifentanil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>propofol</intervention_name>
    <description>intravenous anesthetic</description>
    <arm_group_label>Propofol+Remifentanil</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        From other study results, average NPi for Sevoflurane and propofol were 3.6, 4.2, and&#xD;
        standard deviation was 0.1, 0.4 respectively. Using Gpower program, total of 18 patients&#xD;
        were required. Considering 20% of drop-out rate, total of 22 patients(18+3.6 patients) were&#xD;
        to be recruited.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pediatric patients undergoing general anesthesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  If injection of any agents that can change pupil size or index&#xD;
&#xD;
          -  Any severe side effects, adverse drug reaction&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hee-Soo Kim, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sang-Hwan Ji, M.D., M.S.</last_name>
    <phone>+82-2-2072-3661</phone>
    <email>taepoongshin@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hee-Soo Kim, PhD</last_name>
      <phone>+82220723659</phone>
      <email>dami0605@snu.ac.kr</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>June 13, 2019</study_first_submitted>
  <study_first_submitted_qc>June 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 17, 2019</study_first_posted>
  <last_update_submitted>August 12, 2020</last_update_submitted>
  <last_update_submitted_qc>August 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Hee-Soo Kim</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pupil Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

